These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
302 related items for PubMed ID: 15746944
1. Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanoma. Okada Y, Okada N, Mizuguchi H, Hayakawa T, Nakagawa S, Mayumi T. Cancer Gene Ther; 2005 Jul; 12(7):608-16. PubMed ID: 15746944 [Abstract] [Full Text] [Related]
4. Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice. Okada N, Masunaga Y, Okada Y, Mizuguchi H, Iiyama S, Mori N, Sasaki A, Nakagawa S, Mayumi T, Hayakawa T, Fujita T, Yamamoto A. Gene Ther; 2003 Oct; 10(22):1891-902. PubMed ID: 14502218 [Abstract] [Full Text] [Related]
7. An investigation of adverse effects caused by the injection of high-dose TNFalpha-expressing adenovirus vector into established murine melanoma. Okada Y, Okada N, Mizuguchi H, Hayakawa T, Mayumi T, Mizuno N. Gene Ther; 2003 Apr; 10(8):700-5. PubMed ID: 12692598 [Abstract] [Full Text] [Related]
8. Tumor suppressive efficacy through augmentation of tumor-infiltrating immune cells by intratumoral injection of chemokine-expressing adenoviral vector. Okada N, Sasaki A, Niwa M, Okada Y, Hatanaka Y, Tani Y, Mizuguchi H, Nakagawa S, Fujita T, Yamamoto A. Cancer Gene Ther; 2006 Apr; 13(4):393-405. PubMed ID: 16224496 [Abstract] [Full Text] [Related]
9. Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy. Lanuti M, Gao GP, Force SD, Chang MY, El Kouri C, Amin KM, Hughes JV, Wilson JM, Kaiser LR, Albelda SM. Hum Gene Ther; 1999 Feb 10; 10(3):463-75. PubMed ID: 10048398 [Abstract] [Full Text] [Related]
11. Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy. Lambright ES, Amin K, Wiewrodt R, Force SD, Lanuti M, Propert KJ, Litzky L, Kaiser LR, Albelda SM. Gene Ther; 2001 Jun 10; 8(12):946-53. PubMed ID: 11426335 [Abstract] [Full Text] [Related]
13. A comparison of the properties of different retroviral vectors containing the murine tyrosinase promoter to achieve transcriptionally targeted expression of the HSVtk or IL-2 genes. Vile R, Miller N, Chernajovsky Y, Hart I. Gene Ther; 1994 Sep 10; 1(5):307-16. PubMed ID: 7584096 [Abstract] [Full Text] [Related]
14. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo. Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K. J Gene Med; 2004 Mar 10; 6(3):288-99. PubMed ID: 15026990 [Abstract] [Full Text] [Related]
18. Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanoma. Liu Y, Ye T, Sun D, Maynard J, Deisseroth A. Hum Gene Ther; 2004 Jul 10; 15(7):637-47. PubMed ID: 15242524 [Abstract] [Full Text] [Related]